United States · Bill · S
S. 2562 (107th)
Inflammatory Bowel Disease Act
Introduced
23 May 2002
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4852)
Sponsors
—
Subjects
Discovery layer
Source updated
19 August 2025
Summary
Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research. Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness. Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies. Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 23 May 2002
Introduced in Senate (PDF)
Introduced in Senate · EN · 23 May 2002
Introduced in Senate
summary · EN · 23 May 2002
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/senate-bill/2562
- Open data entity: https://api.congress.gov/v3/bill/107/s/2562